Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Renal Failure is Scopus-indexed (Q2, CiteScore 4.5), WoS SCIE, DOAJ. Published by Taylor and Francis Ltd..
Checked against the index lists dated .
ISSN 0886-022XVerify ISSN ↗1525-6049Verify ISSN ↗
Publisher: Taylor and Francis Ltd.
Cost to publish: Checking DOAJ for article charges…
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Nephrology | 25 / 88 | 72nd | Q2 |
| Critical Care and Intensive Care Medicine | 35 / 122 | 71st | Q2 |
Not listed in: ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 1989–present (also 1987, 1976–1985), best quartile Q2, CiteScore 4.5.
Renal Failure is Q2 in Nephrology (rank 25 of 88) and Q2 in Critical Care and Intensive Care Medicine (rank 35 of 122), by CiteScore 2025.
Renal Failure is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 4.5, which places it in quartile Q2 at the 72nd percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.946, quartile Q1, with an H-index of 76.
The publisher lists an article processing charge of about US$2,306 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Renal Failure is published by Taylor and Francis Ltd. Its print ISSN is 0886-022X and its online ISSN is 1525-6049.
Yes — indexed in the Science Citation Index Expanded.
Yes — it is an open-access journal, listed in DOAJ.
Renal Failure has an h-index of 88 and a 2-year mean of 4.15 citations per paper (OpenAlex). Its Scopus CiteScore is 4.5, quartile Q2. On 2-year citations it ranks #4 of 87 Scopus journals in Nephrology.
Renal Failure published 621 papers in 2025. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 98 research articles (2026), authors are most often from China (69.9%), Taiwan (5.6%) and United States (4.1%). More than half of recent authorship comes from one country.
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. 18 retracted papers are recorded (2.7 per 1,000 papers). The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.